Infective endocarditis in intravenous drug abusers and HIV-1 infected patients (Q34715522)

4 August 2017

1 reference

title

Infective endocarditis in intravenous drug abusers and HIV-1 infected patients (English)

1 reference

4 August 2017

infective endocarditis

1 reference

José M Miró

1

1 reference

PubMed ID

12092473

4 August 2017

Ana del Río

series ordinal

2

1 reference

PubMed ID

12092473

4 August 2017

Carlos A Mestres

series ordinal

3

1 reference

4 August 2017

1 June 2002

1 reference

Infectious Disease Clinics of North America

4 August 2017

1 reference

4 August 2017

16

1 reference

4 August 2017

2

1 reference

4 August 2017

273-95, vii-viii

1 reference

The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

From the Alcohol, Drug Abuse, and Mental Health Administration. Serious infections other than human immunodeficiency virus among intravenous drug abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Selective survival in pentazocine and tripelennamine of Pseudomonas aeruginosa serotype O11 from drug addicts.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Outbreak of endocarditis caused by Pseudomonas aeruginosa serotype O11 among pentazocine and tripelennamine abusers in Chicago

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and review

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Infective endocarditis in the narcotic addict

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Infectious complications in drug addicts: seven-year review of 269 hospitalized narcotics abusers in Switzerland.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Cocaine use and the risk for endocarditis in intravenous drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

A review of endocarditis in acquired immunodeficiency syndrome and human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Serratia marcescens Endocarditis: A Regional Illness Associated with Intravenous Drug Abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Subacute and acute endocarditis due to pseudomonas cepacia in heroin addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich, Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Infective endocarditis following human-to-human enterococcal transmission: a complication of intravenous narcotic abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Increased rate of carriage of Staphylococcus aureus among narcotic addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Staphylococcal Endocarditis in Parenteral Drug Abusers: Source of the Organism

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Microbiologic study of street heroin and injection paraphernalia.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Antimicrobial activity of street heroin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Systemic candidiasis in Spanish heroin addicts: a possible source of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Septic pulmonary emboli. A rare cause of bilateral pneumothorax in drug abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

The febrile parenteral drug user: a prospective study in 121 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Tricuspid valve endocarditis due to Staphylococcus aureus. Correlation of two-dimensional echocardiography with clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Right-sided endocarditis in intravenous drug users. Prognostic features in 102 episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Echocardiographic and clinical correlates in drug addicts with infective endocarditis. Implications of vegetation size

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Transesophageal echocardiography in right-sided endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Results of surgical treatment for infective endocarditis in intravenous drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

New guidelines for the antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Short-course antibiotic therapy for right-sided endocarditis caused by Staphylococcus aureus in injection drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Valve site-specific pathogenetic differences between right-sided and left-sided bacterial endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Antimicrobial Therapy of Experimental Endocarditis Caused by Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Right-sided endocarditis caused by Staphylococcus aureus in drug abusers.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: Prospective randomized comparison with parenteral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Vancomycin pharmacokinetics in burn patients and intravenous drug abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Indications for cardiac surgery in patients with active infective endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Infective endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type 1-negative and -positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Infective endocarditis in injection drug users: importance of human immunodeficiency virus serostatus and degree of immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Influence of human immunodeficiency virus 1 infection and degree of immunosuppression in the clinical characteristics and outcome of infective endocarditis in intravenous drug users.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Cardiopulmonary bypass in HIV-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Cardiac surgery in HIV-positive intravenous drug addicts: influence of cardiopulmonary bypass on the progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Human immunodeficiency virus infection and infective endocarditis among injecting drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

HTLV-II and bacterial infections among injection drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Infective endocarditis in intravenous drug users: does HIV status alter the presenting temperature and white blood cell count?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Cardiac manifestations of acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Cardiac manifestations of HIV/AIDS: a review of disease spectrum and clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Aspergillus endocarditis and myocarditis in a patient with the acquired immunodeficiency syndrome (AIDS). A review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Treatment of AIDS-associated heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

AIDS and the heart: Review and consideration of pathogenetic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Opportunistic Infections and Kaposi's Sarcoma Among Haitians: Evidence of a New Acquired Immunodeficiency State

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Native valve endocarditis due to Pseudallescheria boydii in a patient with AIDS: case report and review.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Endocarditis due to Listeria monocytogenes and human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

Case report: Candida zeylanoides infective endocarditis complicating infection with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2801%2900008-3

7 January 2021

10.1016/S0891-5520(01)00008-3

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12092473